![Elypta](/sites/default/files/styles/portrait/public/medien/speakers/logoventurewinner22elypta-1.jpg?h=42584ab7&itok=05Cud9Wk)
Elypta
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome as system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program with core indications in multi-cancer early detection and surveillance of recurrence in renal cell carcinoma.